Collaborative Drug Therapy Management and Comprehensive Medication Management―2015

Abstract

The American College of Clinical Pharmacy (ACCP) previously published position statements on collaborative drug therapy management (CDTM) in 1997 and 2003. Since 2003, significant federal and state legislation addressing CDTM has evolved and expanded throughout the United States. CDTM is well suited to facilitate the delivery of comprehensive medication management (CMM) by clinical pharmacists. CMM, defined by ACCP as a core component of the standards of practice for clinical pharmacists, is designed to optimize medication-related outcomes in collaborative practice environments. New models of care delivery emphasize patient-centered, team-based care and increasingly link payment to the achievement of positive economic, clinical, and humanistic outcomes. Hence clinical pharmacists practicing under CDTM agreements or through other privileging processes are well positioned to provide CMM. The economic value of clinical pharmacists in team-based settings is well documented. However, patient access to CMM remains limited due to lack of payer recognition of the value of clinical pharmacists in collaborative care settings and current health care payment policy. Therefore, the clinical pharmacy discipline must continue to establish and expand its use of CDTM agreements and other collaborative privileging mechanisms to provide CMM. Continued growth in the provision of CMM by appropriately qualified clinical pharmacists in collaborative practice settings will enhance recognition of their positive impact on medication-related outcomes.

A Call to Action to Transform Pharmacy Education and Practice in the Arab World

“…1,2 Pharmacists are moving beyond dispensing medications toward more advanced services such as comprehensive medication safety systems, collaborative drug therapy management, and improving transitions of care. 3,4 However, transforming patient care services require educated and qualified clinical pharmacists as well as trained educators to support their deployment and maintenance. 5 The educational system and governmental regulatory structures in place should match both the health care needs of the people in a particular country or area and the capabilities and training of the members of the health care team.…”

Diversion Alert: 1-Year Evaluation Across Northern New England, 2013–2014

“…Given this agreed-upon concern of pharmacists and their expanding role potentially afforded by the Affordable Care Act (17), Diversion Alert could be a useful tool, in addition to the PDMP, to screen patients before filling an opioid prescription. McCall and colleagues found in a study that linked Diversion Alert arrest data to patient PDMP records that Diversion Alert data complement PDMP data; 76% of individuals charged with prescription drug trafficking in 2014 did not have a matching record in Maine’s PDMP (18).…”

Student Perceptions of the Pharmacist’s Approach Across the Varying Levels of Medication Therapy Management Services

“…The lecture's content and objectives were directly derived from the Community Pharmacy Foundation's resource, "Get the medications right: a nationwide snapshot of expert practices," as well as a position statement paper from ACCP. 12,14 All 158 P3 students enrolled in the course at the University of Tennessee Health Science Center College of Pharmacy were eligible to participate in the study. Participation was voluntary, and students were asked to complete the online survey on their own time outside of class and within one week of the previously described lecture in the fall of 2015.…”

“…So-called comprehensive medication management (CMM) is a newly defined level of care that encompasses a more complete application of the pharmacist's expertise when providing direct patient care services as part of a patient care team. 12 Like a CMR, a CMM is direct patient care aimed at improving a patient's health through optimal medication use. However, CMM also includes the assessment of the patient's clinical status, clinically appropriate follow-up evaluation appointments, as well as collaboration among members of the health care team, usually under a collaborative practice agreement.…”